Results 251 to 260 of about 5,215,493 (360)

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Nature Reviews Clinical Oncology, 2018
D. Fukumura, Jonas Kloepper, Zohreh Amoozgar, D. Duda, R. Jain   +4 more
semanticscholar   +1 more source

Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation

Advanced Healthcare Materials, EarlyView.
Ferritin‐doped hybrid nanoparticles triggered accurate tumor‐specific hemorrhage for enhanced in situ photothermal therapy and evoked anti‐tumor immunity. Notably, HFn/GA‐Fe specifically induced tumor hemorrhage 12 h after intravenous injection, resulting in visible color darkening. Through photoacoustic imaging, tumor vessels could be clearly observed
Haidong Zha, Xiao Liang, Long Xi, Jiamao Chen, Wenzhao Zhong, Zhen Yuan, Meng Xu, Ying Zheng   +7 more
wiley   +1 more source

MicroRNAs Modulating Cancer Immunotherapy Mechanisms and Therapeutic Synergies. [PDF]

Cancers (Basel)
Mangang NL, Gargasz SK, Murugan SG, Kumar M, Shukla GC, Vijayaraghavalu S.   +5 more
europepmc   +1 more source

Pan-cancer analysis identified DOK3 as a novel biomarker for predicting prognosis and immunotherapy effectiveness

Zichen Xu, Lin Cai, Qingkun Jiang, Yuqi Xin, Shaoqing Chen, Jianwei Liu   +5 more
openalex   +1 more source

Tunable Enhancement of T Cell Expansion Through Modulation of Stiffness and Adhesion Receptor Engagement in an Engineered Hydrogel Platform

Advanced Materials, EarlyView.
We develop a hydrogel scaffold with controlled substrate stiffness and ligand functionalization for cell culture. Stiff substrates presenting CD3/CD28/CD2 ligands induce 2000‐fold expansion of T cells; this is 68% greater than the clinical standard (Dynabeads) and the first hydrogel capable of large‐scale expansion. Although expanding at a lower yield,
Niroshan Anandasivam, Rabia Ali, Lordean Gustinvil, Matthew J. Rosenwasser, Iain E. Dunlop, Derfogail Delcassian   +5 more
wiley   +1 more source

OX40L and IL-2 combination strategy for gastric cancer immunotherapy. [PDF]

Transl Cancer Res
Hu B, Garbarino E, Ma J, Yan C, Jia J, Xie H, Li L, Jin C, Xue Y, Tang H.   +9 more
europepmc   +1 more source

Exploration of the Mechanism of Action of Immune Checkpoint Inhibitors and Their Advancements in Cancer Immunotherapy [PDF]

Qian Wu
openalex   +1 more source

PiP‐Plex: A Particle‐in‐Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells

Advanced Materials, EarlyView.
Detecting proteins secreted by a single cell while retaining its viability remains challenging. A particles‐in‐particle (PiPs) system made by co‐encapsulating barcoded microparticles (BMPs) with a single cell inside an alginate hydrogel particle is introduced.
Félix Lussier, Byeong‐Ui Moon, Mojra Janta‐Polczynski, Yonatan Morocz, Fabian Svahn, Molly Shen, Ljuboje Lukic, Lidija Malic, Teodor Veres, Andy Ng, David Juncker   +10 more
wiley   +1 more source

Tertiary lymphoid structures in the era of cancer immunotherapy

Nature Reviews. Cancer, 2019
C. Sautès-Fridman, F. Petitprez, J. Calderaro, W. Fridman   +3 more
semanticscholar   +1 more source

Novel Toll-like Receptor 2 Ligands for Targeted Pancreatic Cancer Imaging and Immunotherapy

, 2012
Amanda S. Huynh, Woo Jin Chung, Hyun-Il Cho, Valerie E. Moberg, Esteban Celis, David L. Morse, Josef Vágner   +6 more
openalex   +2 more sources